Target intelligence / Profile preview

Novel transcript, antisense to TPP1

Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA
01

Overview

ENSG00000304335 is a long non-coding RNA transcript located antisense to the TPP1 gene. As an lncRNA, it does not encode a protein but may play a regulatory or structural role at the RNA level. There is currently no published evidence directly connecting this transcript to well-characterized biological processes, clinical phenotypes, or therapeutic drug targeting. Its annotation and naming may vary across databases and is not standardized in the scientific literature[3]. The entry refers to a non-coding RNA, not the "Tripeptidyl-peptidase 1" protein (TPP1), which is a well-characterized lysosomal enzyme involved in late-infantile neuronal ceroid lipofuscinosis (CLN2)[1][2][4][5][7]. Therefore, this transcript should not be treated as a conventional drug target, receptor, enzyme, or biomarker. For comprehensive pharmaceutical or biomedical research, the protein-coding TPP1 would be the relevant gene, not this antisense lncRNA[3].

Other names
ENSG00000304335novel antisense transcript to TPP1TPP1-antisense (generic)

Beyond the preview

Go deeper on Novel transcript, antisense to TPP1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to TPP1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call